Loading...
XNAS
IRTC
Market cap5.75bUSD
Dec 05, Last price  
178.37USD
1D
-1.64%
1Q
-1.48%
Jan 2017
494.57%
IPO
591.62%
Name

iRhythm Technologies Inc

Chart & Performance

D1W1MN
XNAS:IRTC chart
P/E
P/S
9.71
EPS
Div Yield, %
Shrs. gr., 5y
4.31%
Rev. gr., 5y
22.50%
Revenues
592m
+20.13%
15,368,00021,749,00036,140,00064,072,00098,509,000147,293,000214,552,000265,166,000322,825,000410,921,000492,681,000591,839,000
Net income
-113m
L-8.20%
-13,589,000-15,832,000-22,799,000-20,903,000-29,420,000-48,280,000-54,568,000-43,830,000-101,361,000-116,155,000-123,406,000-113,289,000
CFO
3m
P
-11,849,000-15,626,000-18,005,000-16,651,000-14,911,000-29,068,000-21,863,000-13,759,000-37,753,000-23,012,000-50,101,0003,390,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
IPO date
Oct 20, 2016
Employees
1,793
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT